TABLE 2.
Follow-Up Care
| Brain, No. (%) | Spine, No. (%) | Sample, No. (%) | |
|---|---|---|---|
| Concomitant medication | |||
| Antiseizure | 22 (19) | 22 (15) | 44 (17) |
| Antidepressant | 27 (24) | 35 (23) | 62 (24) |
| Corticosteroid | 6 (5) | 5 (3) | 11 (4) |
| Pain | 24 (21) | 59 (39) | 83 (31) |
| Follow-up physiciana | |||
| Neurosurgeon | 56 (49) | 84 (56) | 140 (53) |
| Neuro-oncologist | 37 (33) | 40 (27) | 77 (29) |
| Oncologist | 10 (9) | 9 (6) | 19 (7) |
| Radiation oncologist | 20 (18) | 15 (10) | 35 (13) |
| Family physician | 16 (14) | 28 (19) | 44 (17) |
| Other | 15 (13) | 19 (13) | 34 (13) |
| Frequency of MRI | |||
| Every 2 mo | 15 (15) | 10 (7) | 25 (11) |
| Every 6 mo | 26 (26) | 26 (19) | 52 (22) |
| Every year | 24 (24) | 33 (24) | 57 (24) |
| Every 2 y | 1 (1) | 9 (7) | 10 (4) |
| Only when there was a concern | 4 (4) | 2 (2) | 6 (3) |
| >2 y since last MRI | 2 (2) | 12 (9) | 14 (6) |
Abbreviation: MRI, magnetic resonance imaging.
All data are from patient self-reports, and they have not been verified with medical records.
The number of patients varies from category to category due to missing data.
a
Common physician combinations (2 or 3 physicians) included the following: family physician and neurosurgeon (34%); neurosurgeon, radiation oncologist, and neuro-oncologist (24%); family physician, neurosurgeon, and oncologist (19%); and neuro-oncologist, neurosurgeon, and family physician (24%).